Q Linea Ab Stock Fundamentals
| QLINEA Stock | SEK 0.77 0.09 10.47% |
Q linea AB fundamentals help investors to digest information that contributes to Q Linea's financial success or failures. It also enables traders to predict the movement of QLINEA Stock. The fundamental analysis module provides a way to measure Q Linea's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Q Linea stock.
QLINEA |
Q linea AB Company Return On Equity Analysis
Q Linea's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Q Linea Return On Equity | -0.72 |
Most of Q Linea's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Q linea AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Q linea AB has a Return On Equity of -0.7175. This is 97.01% lower than that of the Healthcare sector and 88.0% lower than that of the Medical Instruments & Supplies industry. The return on equity for all Sweden stocks is 131.45% higher than that of the company.
Q linea AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Q Linea's current stock value. Our valuation model uses many indicators to compare Q Linea value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Q Linea competition to find correlations between indicators driving Q Linea's intrinsic value. More Info.Q linea AB is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Q Linea by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Q Linea's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.QLINEA Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Q Linea's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Q Linea could also be used in its relative valuation, which is a method of valuing Q Linea by comparing valuation metrics of similar companies.Q Linea is currently under evaluation in return on equity category among its peers.
QLINEA Fundamentals
| Return On Equity | -0.72 | |||
| Return On Asset | -0.4 | |||
| Operating Margin | (13.93) % | |||
| Current Valuation | 287.15 M | |||
| Shares Outstanding | 29.21 M | |||
| Shares Owned By Insiders | 12.15 % | |||
| Shares Owned By Institutions | 74.76 % | |||
| Price To Book | 1.68 X | |||
| Price To Sales | 21.31 X | |||
| Revenue | 9.34 M | |||
| Gross Profit | (24.63 M) | |||
| EBITDA | (221.99 M) | |||
| Net Income | (231.24 M) | |||
| Cash And Equivalents | 15.09 M | |||
| Cash Per Share | 11.76 X | |||
| Debt To Equity | 0.20 % | |||
| Current Ratio | 11.62 X | |||
| Book Value Per Share | 7.78 X | |||
| Cash Flow From Operations | (255.05 M) | |||
| Earnings Per Share | (8.34) X | |||
| Target Price | 50.0 | |||
| Number Of Employees | 156 | |||
| Beta | 0.39 | |||
| Market Capitalization | 391.41 M | |||
| Total Asset | 466.63 M | |||
| Net Asset | 466.63 M |
About Q Linea Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Q linea AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Q Linea using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Q linea AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Q-linea AB researches, develops, manufactures, and sells instruments and disposables for infection diagnostics. Q-linea AB was founded in 2008 and is based in Uppsala, Sweden. Q Linea operates under Medical Instruments Supplies classification in Sweden and is traded on Stockholm Stock Exchange. It employs 61 people.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in QLINEA Stock
Q Linea financial ratios help investors to determine whether QLINEA Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in QLINEA with respect to the benefits of owning Q Linea security.